Stay Informed. Stay Competitive. Get Free Email Updates Dow 30 & Emerging Growth

Stay Informed. Stay Competitive.

Get Free Updates

Dow 30 & Emerging Growth

Pfizer, BioNTech Adds Japan To Coronavirus Vaccine Supply List For First Half of 2021

By John F. Heerdink, Jr.

As per reports, Pfizer (PFE) and BioNTech SE to supply 120 million doses of their experimental coronavirus vaccine to Japan in the first half of 2021. Financial details of the agreement were not disclosed. Earlier, The United States also entered a similar deal with Pfizer and BioNtech for 100 million doses of the potential vaccine for nearly $2 billion.

This week, BioNTech and Pfizer began a large, late-stage trial of their vaccine candidate to test its efficacy. Daiichi Sankyo Co is in talks to provide potential coronavirus vaccine in Japan being developed by the University of Oxford and AstraZeneca Plc.

Pfizer (PFE) is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products. To learn more about Pfizer (PFE) and to track its progress please visit the Vista Partners Pfizer Coverage Page

Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives. 

Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.

Post View Count : 555
(Read Original Story: Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan in Reuters)


Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us